SOURCE: Pharm Control Ltd.

May 25, 2007 09:30 ET

Pharm Control Ltd. Responds to OSC Allegations

NEW YORK, NY -- (MARKET WIRE) -- May 25, 2007 -- The Management of Pharm Control Ltd. (PINKSHEETS: PMCL) would like to notify all shareholders that it vehemently denies any allegations made by the Ontario Securities Commission (OSC) in its Press Release.

The Company will have its lawyers vigorously pursue all avenues to clarify these matters on behalf of its shareholders.

About Pharm Control Ltd.

Pharm Control Ltd. is a leading medicine Research and Development company that is devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. The Company's founders have invested over 10 years of research discovering and developing new and effective non-synthetic medicines to fight disorders and sickness in the modern world.

Safe Harbor Statement

The preceding includes forward-looking statements, which involve known and unknown risks, and uncertainties, which may cause the company's actual results in future periods to differ materially from forecasted results. Any forward-looking statements above are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of factors, including, without limitation, competition, intellectual property rights, litigation, needs of liquidity, and other risks detailed from time to time in the company's reports filed with the SEC. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, but not limited to, continued acceptance of the company's products and services, competition, new products and technological changes, as well as any and all "other risks" associated with business.

Contact Information